9,832
Views
7
CrossRef citations to date
0
Altmetric
Focus on STEMI

Prehospital Nitroglycerin Safety in Inferior ST Elevation Myocardial Infarction

, MDCM, , MD, , PCP, MSc, , PCP, , AEMT-CC, PhD, , MSc & , MD, FRCP, CSPQ, FACEP show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nichole Bosson, Benjamin Isakson, Jayson A. Morgan, Amy H. Kaji, Atilla Uner, Katherine Hurley, Timothy D. Henry & James T. Niemann. (2019) Safety and Effectiveness of Field Nitroglycerin in Patients with Suspected ST Elevation Myocardial Infarction. Prehospital Emergency Care 23:5, pages 603-611.
Read now

Articles from other publishers (6)

N. Cavanagh, I. E. Blanchard, D. Weiss & W. Tavares. (2023) Looking back to inform the future: a review of published paramedicine research. BMC Health Services Research 23:1.
Crossref
Matt Wilkinson-Stokes, Jason Betson & Simon Sawyer. (2023) Adverse events from nitrate administration during right ventricular myocardial infarction: a systematic review and meta-analysis. Emergency Medicine Journal 40:2, pages 108-113.
Crossref
Joseph P. Ornato, Michael R. Sayre & James I. Syrett. 2021. Emergency Medical Services. Emergency Medical Services 90 99 .
Matt Wilkinson-Stokes. (2021) Right Ventricular Myocardial Infarction and Adverse Events from Nitrates: A Narrative Review. Australasian Journal of Paramedicine 18, pages 1-8.
Crossref
Matt Wilkinson-Stokes, Marc Colbeck & Scott Stewart. (2021) Adverse events from nitrate administration during right ventricular myocardial infarction: a systematic review protocol. JBI Evidence Synthesis 19:9, pages 2415-2422.
Crossref
Marzia Buscema, Sofiya Matviykiv, Tamás Mészáros, Gabriela Gerganova, Andreas Weinberger, Ute Mettal, Dennis Mueller, Frederik Neuhaus, Etienne Stalder, Takashi Ishikawa, Rudolf Urbanics, Till Saxer, Thomas Pfohl, János Szebeni, Andreas Zumbuehl & Bert Müller. (2017) Immunological response to nitroglycerin-loaded shear-responsive liposomes in vitro and in vivo. Journal of Controlled Release 264, pages 14-23.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.